Duke Using Illumina GA to Study HIV Resistance | GenomeWeb

NEW YORK (GenomeWeb News) — Duke University will use Illumina's Genome Analyzer to search for genetic variations that may enable some people to be resistant to HIV infections, the company said today.

Researchers at the Center for Human Genome Variation at Duke's Institute for Genome Sciences and Policy will use the technology to sequence the complete genome of at least 50 individuals.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.